Emile Latour

4PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Workforce planningMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 09, 2025
Ribociclib in Sequential Combination with Doxorubicin in Anthracycline-Naïve Advanced Soft-Tissue Sarcomas: Results of a Dose-Finding Phase Ib Study.

Lara E Davis, Limin Zhu, Emile Latour

|Jan 22, 2025
Characterizing Physician and WIC Staff Experiences During the 2022 Infant Formula Shortage in Oregon.

Sarah Dzubay, Megha Arora, Emile Latour

|May 20, 2020
Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance.

Joshi J Alumkal, Duanchen Sun, Eric Lu

|May 26, 2019
Quality of life remains poor for patients with pemphigus vulgaris despite targeted therapies.

Brittney Schultz, E Latour, N Fett

Pageof 1